DekaBank Deutsche Girozentrale - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 128 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$292,000
+68.8%
19,500
+38.3%
0.00%
+50.0%
Q1 2016$173,000
-34.2%
14,100
-15.1%
0.00%
-33.3%
Q4 2015$263,000
+6.5%
16,600
+3.1%
0.00%0.0%
Q3 2015$247,000
-34.5%
16,100
+3.9%
0.00%
-25.0%
Q2 2015$377,000
+8.0%
15,500
+3.3%
0.00%0.0%
Q1 2015$349,000
-20.1%
15,000
-12.3%
0.00%
-33.3%
Q4 2014$437,000
-24.9%
17,100
-8.6%
0.01%
-25.0%
Q3 2014$582,000
+23.0%
18,700
+2.2%
0.01%
+14.3%
Q2 2014$473,000
+3.3%
18,300
-6.6%
0.01%0.0%
Q1 2014$458,00019,6000.01%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 453,392$11,022,0001.89%
GREAT POINT PARTNERS LLC 141,900$3,450,0001.34%
Penn Capital Management Company, LLC 1,247,428$30,325,0001.25%
Ranger Investment Management 982,240$23,878,0001.16%
HealthCor Management, L.P. 912,381$22,180,0001.12%
Piermont Capital Management Inc. 138,380$3,364,0001.02%
JW Asset Management, LLC 111,630$2,714,0000.82%
SECTORAL ASSET MANAGEMENT INC 465,625$11,319,0000.47%
ACUTA CAPITAL PARTNERS, LLC 28,000$681,0000.42%
Tekla Capital Management LLC 409,500$9,955,0000.36%
View complete list of SAGENT PHARMACEUTICALS INC shareholders